TMS Measures of Plasticity and Excitatory/Inhibitory Ratio as Biomarkers for R-baclofen Effects in Normal Volunteers

Trial Profile

TMS Measures of Plasticity and Excitatory/Inhibitory Ratio as Biomarkers for R-baclofen Effects in Normal Volunteers

Discontinued
Phase of Trial: Phase I

Latest Information Update: 26 Aug 2015

At a glance

  • Drugs Arbaclofen (Primary)
  • Indications Pervasive child development disorders
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 09 Mar 2012 Planned end date changed from 1 Jul 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.
    • 09 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 15 Jun 2011 Actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top